1.
Table1_Biosimilar Use and Switching in Belgium: Avenues for Integrated Policymaking.DOCX
2.
datasheet1_Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis.docx
3.
4.
5.
6.
7.
8.
9.
DataSheet1_Implementing the EU HTA regulation: Insights from semi-structured interviews on patient expectations, Belgian and European institutional perspectives, and industry outlo...
DataSheet1_Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care.PDF
Data_Sheet_1_Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and Practice.docx
DataSheet1_Key Determinants of Health-Related Quality of Life Among Advanced Lung Cancer Patients: A Qualitative Study in Belgium and Italy.docx